Prevention of venous thromboembolism in hematologic neoplasms: An expert consensus from sehh–seth

• J. R. Gonzalez-Porras ^[1] ; J. Mateo ^[2] ; V. Gonzalez-Calle ^[1] ; P. Marco ^[3] ; V. Garcia-Gutierrez ^[4] ; J. C. Reverter ^[6] ; R. Lecumberri ^[5]
  1. [1] Hospital Universitario de Salamanca

     Hospital Universitario de Salamanca

     Salamanca, España

     
  2. [2] Hospital de la Santa Creu i Sant Pau

     Hospital de la Santa Creu i Sant Pau

     Barcelona, España

     
  3. [3] Hospital General Universitario de Alicante

     Hospital General Universitario de Alicante

     Alicante, España

     
  4. [4] Hospital Ramón y Cajal

     Hospital Ramón y Cajal

     Madrid, España

     
  5. [5] Clínica Universitaria de Navarra

     Clínica Universitaria de Navarra

     Pamplona, España

     
  6. [6] Hematology Department, Hospital Clinic, Barcelona, Spain

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 5 (May), 2022, págs. 770-783
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are scarce, limiting the development of evidence-based thromboprophylaxis guidelines. The present position paper is addressed to all hematologists treating patients affected by hematologic neoplasms with the aim to provide clinicians with a useful tool for the prevention of VTE.